SMTL ID : 3ans.1

Human soluble epoxide hydrolase in complex with a synthetic inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.98 Å

Oligo State

homo-dimer

Ligands

2 x S38: 4-cyano-N-[(1S,2R)-2-phenylcyclopropyl]benzamide(Non-covalent)

S38.1: 12 residues within 4Å: Chain A: F.48, D.116, W.117, M.120, Y.164, Q.165, F.168, L.189, M.200, L.209, Y.247, H.305 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:F.48, A:Y.164, A:Y.164, A:F.168, A:L.189, A:L.209 Hydrogen bonds: A:D.116, A:Y.164 pi-Stacking: A:W.117 S38.2: 13 residues within 4Å: Chain B: F.48, D.116, W.117, M.120, Y.164, Q.165, F.168, L.189, M.200, L.209, Y.247, L.280, H.305 11 PLIP interactions: 11 interactions with chain B Hydrophobic interactions: B:F.48, B:F.48, B:Y.164, B:Y.164, B:F.168, B:L.189, B:L.209, B:L.280 Hydrogen bonds: B:D.116, B:Y.247 pi-Stacking: B:W.117

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Tanaka, D. et al., A practical use of ligand efficiency indices out of the fragment-based approach: ligand efficiency-guided lead identification of soluble epoxide hydrolase inhibitors. J.Med.Chem. (2011)

Release Date

2011-01-19

Peptides

Epoxide hydrolase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Epoxide hydrolase 2

Related Entries With Identical Sequence